Biopharmaceuticals Market Research Reports & Industry Analysis
Biopharmaceuticals are a class of drugs produced using living organisms or their cellular components to treat various medical conditions. By providing highly targeted and sophisticated therapeutic options, biopharmaceuticals have revolutionized the field of medicine. If you are in search of comprehensive and objective data on this fast-growing market, you have come to the right place. MarketResearch.com offers hundreds of biopharmaceuticals industry reports published by leading research firms.
New Biopharmaceuticals Market Research
- Use our reports to explore diverse markets in the biopharmaceuticals industry, from biosimilars to enzymes to antibodies.
- Gain invaluable insights, including biopharmaceuticals market size, growth, and industry trends.
- Get up to speed on the latest technological breakthroughs, opportunities, and market-entry strategies.
Proven Expertise in the Field of Market Research
With a track record spanning more than two decades, MarketResearch.com is a trusted source for market research. We serve top-tier investment banks, management consulting firms, and Fortune 500 multinational corporations. Our dedicated research specialists are here to provide recommendations and guidance throughout your research process. Improve your knowledge and enhance your strategies with biopharmaceutical market research from MarketResearch.com today.
Biopharmaceuticals Industry Research & Market Reports
-
Etanercept– Biosimilar Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Etanercept Understanding ... Read More
-
Teriparatide– Biosimilar Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Teriparatide Understanding ... Read More
-
Follitropin alfa– Biosimilar Insight, 2022
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage ... Read More
-
Ranibizumab-Biosimilars Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Ranibizumab Understanding ... Read More
-
Epoetin alfa– Biosimilar Insight, 2022
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage ... Read More
-
Pharmaceutical Sterility Testing Market - By Type (In-House And Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, And Bacterial Endotoxin Testing), By Sample (Sterile Drugs, Medical Devices, And Biologics & Therapeutics), By End-Use (Compounding Pharmacies, Medical Devices Companies, And Pharmaceutical Companies), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030
... Medical Devices Companies, And Pharmaceutical Companies), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030 Market Overview Fatpos Global has released a report titled Pharmaceutical Sterility Testing Market - Analysis of ... Read More
-
Filgrastim - Biosimilar Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Filgrastim Understanding ... Read More
-
Somatotropin - Biosimilar Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Somatropin Understanding ... Read More
-
Adalimumab-Biosimilars Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Adalimumab Understanding ... Read More
-
Rituximab-Biosimilars Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Rituximab Understanding ... Read More
-
Insulin Glargine- - Biosimilar Insight, 2022
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage ... Read More
-
Biologics - Market Insights, Competitive Landscape and Market Forecast–2026
... By Manufacturing Type (In-House And Outsourced), and by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising prevalence of autoimmune disorders such as rheumatoid arthiritis and genetic disorders Global ... Read More
-
Biopharmaceuticals Market by Product (Monoclonal Antibody, Interferon, Insulin, Growth and Coagulation Factor, Erythropoietin, Vaccine, Hormone, And Others) and by Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, And Others)- Global Opportunity Analysis and Industry Forecast 2022-2030
... Opportunity Analysis and Industry Forecast 2022-2030 The Biopharmaceuticals Market was valued at USD 345.84 billion in 2021 and is predicted to reach USD 974.48 billion by 2030 with a CAGR of 11.7% from 2022-2030. Biopharmaceutical ... Read More
-
Bevacizumab-Biosimilars Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Bevacizumab Understanding ... Read More
-
Infliximab-Biosimilars Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Infliximab Understanding ... Read More
-
Interferon - Biosimilar Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Interferon Understanding ... Read More
-
Trastuzumab-Biosimilars Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Trastuzumab Understanding ... Read More
-
Darbepoetin alfa– Biosimilar Insight, 2022
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage ... Read More
-
Pegfilgrastim– Biosimilar Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Pegfilgrastim Understanding ... Read More
-
Japan Biosimilars: Landscape Today, Outlook Tomorrow
... of biosimilar tool to curb healthcare cost Biosimilars uptake varies as per each opportunity, Remicade BS vs. Rituxan BS Two poles of the curve A few skipping NHI listing due to manufacturing issues associated with ... Read More
-
Biosimilar Market Trends 2019
... therapeutic equivalents of brand name drugs. However, biosimilars are not generic biologics because there can be no generic form of biologics due to the complex process of creating biologics. Biosimilar Market Trends 2019 is designed ... Read More
-
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics
... Biologics Summary The Global Biosimilar market by product is projected to grow at a compound annual growth rate (CAGR) of 45.22%. The market is driven mainly by a constrained payer environment and patent expiration of ... Read More
-
World Market for Biopharmaceutical Drug Delivery Device Technology
... injections are not the first choice among patients and compliance is an ongoing issue. Further, as the majority of new entities in development are biologics requiring advanced drug delivery, manufacturers of devices have been busy ... Read More
-
In Vitro Toxicology Market
... study aims to derive crucial insights that will benefit all the major stakeholders of the industry in developing strategic business plans based on these emerging trends. The report provides market size and growth trends for ... Read More
-
Pharmaceutical Market Research Bundle (Monoclonal Antibody Markets, CMOs, Bioprocessing Markets, Biosimilar Drug Markets)
... combination of 4 complete Kalorama Information reports, including the following: What's Trending in Monoclonal Antibodies Biopharmaceutical Contract Manufacturing Organization Markets Single-Use Upstream Bioprocessing Markets The World Market for Biosimilars The reports are separate PDFs, exactly ... Read More
Research Assistance
